Sinovac Life Sciences Co., Ltd.

This early-stage trial tests a new vaccine designed to protect against several types of meningococcal bacteria that cause meningitis. About 150 healthy volunteers aged 2 to 59 will receive the vaccine or a placebo to check its safety and how well it triggers an immune response. T…